Featured news
-
Genomic study helps detect baby’s rare growth condition
Baby Safi started treatment for a rare growth condition after participating in the Generation Study, a national genomic screening study
-
Rare Disease Day (28 Feb) is nearly here
Rare Disease Day is a globally coordinated movement dedicated to rare diseases, striving for equity in social opportunities, healthcare, and access to diagnosis and therapies for people living with a rare disease.
-
Genomics Primer4Pharmacy course
We have an exciting opportunity for those working in pharmacy in the East Genomics region (East Midlands and East of England) to attend a one day Genomics Primer4Pharmacy course.
-
Public and patient involvement opportunities
Here are details of a couple of great opportunities for patients and the public in the East Midlands and East of England to get involved and help shape decisions about genomics in our region.
-
National Cancer Plan launched
The National Cancer Plan, launched on 4 February 2026, sets out England’s next major phase of change to improve cancer outcomes over the coming decade.
-
Leukaemia testing in Leicester helps patients to access tailored treatments
By offering IDH1 testing in AML, the lab are helping people to access targeted treatments sooner
All news
Showing 20 results
New Year Honours for Cambridge clinicians
Two New Year Honours have been awarded to clinicians at Cambridge University Hospitals NHS Foundation Trust who are known for their work in genomics.
Cystic Renal Disease: Genomics Workshops
We are running a series of online workshops from March 2023 on Cystic Renal Disease, to get views on a model of nursing practice that enables equitable access and delivery of genomic care for patients with Cystic Renal Disease.
The 12 (Genomic) Days of Christmas - short animation from NHS East Genomics
A little animation based on The 12 Days of Christmas to introduce you to NHS East Genomics, with some facts and figures and a cameo or two from a certain hirsute, jolly gentleman...
Millions pledged for newborn genetic testing
The government has announced £105 million in funding to speed up diagnosis of rare genetic diseases in newborns, potentially resulting in life-saving interventions for thousands of babies.
Play Domino Talk Health events tackle prostate cancer health inequalities
Members of the local Afro-Caribbean community were invited to a Church in the St. Anne’s area of Nottingham on Monday 5 December to take part in a Play Domino Talk Prostate event run by our United Against Prostate Cancer (UAPC) project team.
Call for wider genetic testing for children with brain tumours
A team of doctors at Addenbrooke’s have highlighted how a simple genetic screening test improved the diagnosis and treatment of a little 17-month old girl with a brain tumour – caused by a rare condition.
RAREfest 2022 at Cambrdige Guildhall Saturday 26 November
Will we see you there?
Public consultation on clinical genomics services in England
Consultation period update
Harnessing the power of genetic testing to improve patient care
The Norfolk and Norwich University Hospital is playing a vital role in the delivery of genomic testing across the East to tailor treatments for patients according to their genetic makeup.
Genetic test rules out cancer for baby Oliver
A baby who was born with a large tumour on his leg has been spared chemotherapy and surgery, after whole genome sequencing at Addenbrooke’s revealed the lump was harmless.
Sharing best practice in WGS for children with cancer
East Genomics together with Wellcome Connecting Science and the University of Cambridge are hosting this one day workshop in October.
Webinar: Harnessing the power of Clinical Nurse Specialists in the rollout of genomics
Organised by the East Genomic Medicine Service Alliance (GMSA) this webinar is aimed at clinical nurse specialists (CNSs) within Cambridge University Hospital NHS Foundation Trust (CUH), North West Anglia Foundation Trust, Royal Papworth Foundation Trust, Norfolk and Norwich NHS Foundation Trust (NNUH), James Paget Foundation Trust, Queen Elizabeth's Hospital King's Lynne Foundation Trust
Large number of stem cell lines carry significant DNA damage, say researchers
Cambridge researchers say detailed genetic characterisation including whole genome sequencing can help ensure safety of cell-based therapies
New clues to treat germ cell tumours
A study by a team from Addenbrooke’s and the Wellcome Sanger Institute has revealed more about the origin of germ cell tumours, usually found in the ovaries and testicles, suggesting new approaches to future treatment.
Webinar: Lynch Syndrome Management
This webinar has been organised by the East Genomic Medicine Service Alliance (East GMSA). It is aimed at all clinicians, nurses, managers & coordinators in primary and secondary care who work with patients with Lynch Syndrome.
Rachel's story: Genomics helped me understand my cancer
Rachel Gilbert was diagnosed with gastrointestinal stromal tumours (GIST) aged 15 and says whole genome sequencing has provided vital answers for her and her family.
How is genomics changing pharmacy?
Genomics is starting to have a huge impact on pharmacy. Recently, genomics is being used to predict how an individual will handle specific drugs to reduce harm and improve outcomes.
Familial Cancer Specialists - a unique team supporting patients with suspected inherited cancer
Wendy Chorley is the Lead Familial Cancer Specialist at University Hospitals of Derby and Burton NHS Foundation Trust. She leads a team of five familial cancer specialists, most of whom are nurses or allied health professionals.
The role of genomics in midwifery
For Genomics Conversation Week 2022, Angela Crosby, Antenatal and Newborn Screening Coordinator, United Lincolnshire Hospitals NHS Trust (ULHT), talks about the role of her team and the impact genomics has in their work.
The importance of identifying patients with Monogenic Diabetes
For Diabetes Week (13 - 19 June), Anita Murphy, our regional Genetic Diabetes Nurse - East Midlands and East of England - has shared with us why it is important for clinicians to consider this type of diabetes when seeing patients and how it can change th